Abtrace
PrivateLast Round
Seed
Aug 26, 2021
Total Funding Raised
$5.16M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Abtrace operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in August 2021.
Abtrace is a healthtech company that provides an AI-driven software platform for proactive monitoring and intelligent recall in primary care settings.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Medical AI, Healthcare Analytics, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abtrace Comparables
Compare Abtrace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medlink Solutions Ltd | 87% | |
| Ardens Health Informatics | 86% | |
| C the Signs | 85% |
For institutional investors. Book with your work email.
Abtrace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 26, 2021 | ||||
| Accelerator | Nov 23, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abtrace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| UKRI Innovate UK | Accelerator |
| EIT Health | Accelerator |
| Faber Ventures | Seed |
| Ganexa Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
Open roles increased from 0 to 23, representing 38% of headcount.
- Aug 22, 2026
Monthly visitors increased 40% MoM, reaching 8.5K.
For institutional investors. Book with your work email.
Abtrace Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abtrace's valuation, stock price, and market status.
Is Abtrace a public or private company?
Abtrace is a private company.
What is the current stock price of Abtrace?
Abtrace is a private company, so its shares have no public market price. Caplight tracks Abtrace's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abtrace worth (valuation)?
Valuation information for Abtrace is not publicly available.
Can I buy Abtrace stock?
Abtrace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abtrace's last funding round?
Abtrace's most recent funding round was Seed on August 26, 2021.
Who are the main investors in Abtrace?
Key investors in Abtrace include Faber Ventures.
Will Abtrace IPO soon?
No public IPO plans have been announced for Abtrace.
How can I track Abtrace secondary market activity?
Caplight tracks bids, offers, and trades in Abtrace's shares on secondary markets.